CraniUS
Recent Finacing
Hybrid B
Recent Raise
$20M
CraniUS Therapeutics is a Baltimore-based neurotechnology company developing NeuroPASS™, a fully implantable skull-embedded platform that bypasses the blood-brain barrier to enable targeted, programmable drug delivery to the brain.
